Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Stock indices move when expectations and data shift; factors like economic data, earnings, and policy news all influence daily movements, shaping market direction.
27,810 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Chipotle and Microsoft have taken divergent paths in 2026. CMG rides restaurant-demand strength while MSFT grapples w...
As AI hype cools, dividend-focused ETFs draw buyers seeking steadiness. HDV delivers a modest yield with a low fee an...
Garmin delivered a dominant Q4 with a big EPS beat and revenue surge, triggering a sharp market rally as investors we...
A clear look at how SiriusPoint may perform in 2025. This guide breaks down underwriting discipline, investment resul...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
KB Home's Q1 2026 results shed light on the company’s earnings trajectory and the housing market dynamics. This guide...
SpaceX’s S-1 filing puts Elon Musk’s Mars ambitions under the public lens, inviting investors to weigh a multi-billio...
Virgin Galactic rockets Monday sparked a split in space stocks as investors rotate away from launch-focused names. Ri...
A once-prolific $1,000 strategy beat the market story has turned into a cautionary tale. New investors face sharp los...
When a chief operating officer sells shares, investors often wonder what it really means. This guide explains how to ...